| 06/23/2026 3:29 PM | GeneDx (1818331) Issuer PFENNIGER RICHARD C JR (1200796) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 3:30 PM | GeneDx (1818331) Issuer RUCH JOSHUA (943431) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 3:31 PM | GeneDx (1818331) Issuer Ryan Jason (1585017) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 7:35 AM | GeneDx (1818331) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2026 7:39 AM | GeneDx (1818331) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/08/2026 4:25 PM | Casdin Capital, LLC (1534261) Reporting Casdin Eli (1534264) Reporting Casdin Partners GP, LLC (1534260) Reporting Casdin Partners Master Fund, L.P. (1534265) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 3:16 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 4:20 PM | CMLS Holdings LLC (1822257) Filed by GeneDx (1818331) Subject | Form SCHEDULE 13D/A | |
| 05/20/2026 6:45 PM | Casdin Capital, LLC (1534261) Reporting Casdin Eli (1534264) Reporting Casdin Partners GP, LLC (1534260) Reporting Casdin Partners Master Fund, L.P. (1534265) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 6:05 PM | CMLS Holdings LLC (1822257) Filed by GeneDx (1818331) Subject | Form SCHEDULE 13D/A | |
| 05/15/2026 6:07 PM | Corvex Management LP (1535472) Reporting GeneDx (1818331) Issuer Meister Keith A. (1307631) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for WGSWW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GeneDx and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/11/2026 8:20 PM | CMLS Holdings LLC (1822257) Filed by GeneDx (1818331) Subject | Form SCHEDULE 13D/A | |
| 05/11/2026 8:21 PM | Corvex Management LP (1535472) Reporting GeneDx (1818331) Issuer Meister Keith A. (1307631) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 7:43 PM | Casdin Capital, LLC (1534261) Reporting Casdin Eli (1534264) Reporting Casdin Partners GP, LLC (1534260) Reporting Casdin Partners Master Fund, L.P. (1534265) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:15 PM | GeneDx (1818331) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/29/2026 5:53 PM | GeneDx (1818331) Subject Stueland Katherine (1689575) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/29/2026 5:55 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/17/2026 5:39 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 5:40 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/11/2026 3:26 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 6:56 AM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 6:54 AM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 6:19 PM | Corvex Management LP (1535472) Reporting GeneDx (1818331) Issuer Meister Keith A. (1307631) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 4:46 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 4:49 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 4:50 PM | Dechairo Bryan (2051759) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 6:02 AM | GeneDx (1818331) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 7:29 AM | GeneDx (1818331) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/23/2026 7:16 AM | GeneDx (1818331) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 7:21 AM | GeneDx (1818331) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/03/2026 6:30 PM | Dechairo Bryan (2051759) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/29/2026 6:25 PM | GeneDx (1818331) Subject Stueland Katherine (1689575) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/29/2026 6:27 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/12/2026 4:10 PM | GeneDx (1818331) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/18/2025 4:18 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 4:20 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 3:29 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 3:31 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/03/2025 3:18 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 3:13 PM | GeneDx (1818331) Issuer RUCH JOSHUA (943431) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 3:30 PM | GeneDx (1818331) Subject RUCH JOSHUA (943431) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free |
| 11/12/2025 5:14 PM | GeneDx (1818331) Subject WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1644956) Filed by | Form SCHEDULE 13G/A | |
| 10/31/2025 3:41 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 3:42 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/28/2025 5:52 AM | GeneDx (1818331) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/28/2025 6:15 AM | GeneDx (1818331) Filer | Form S-3ASR | |
| 10/28/2025 5:43 AM | GeneDx (1818331) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/06/2025 3:23 PM | Corvex Management LP (1535472) Reporting GeneDx (1818331) Issuer Meister Keith A. (1307631) Reporting | Form 4/A | |
| 10/01/2025 3:18 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2025 3:21 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/30/2025 7:04 PM | GeneDx (1818331) Subject Stueland Katherine (1689575) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/30/2025 7:04 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/19/2025 3:10 PM | Fuchs Thomas (2083937) Reporting GeneDx (1818331) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 09/19/2025 3:11 PM | Fuchs Thomas (2083937) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2025 8:50 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4/A | |
| 09/18/2025 5:04 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2025 5:05 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2025 7:16 AM | GeneDx (1818331) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 3:06 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2025 3:07 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2025 11:15 PM | GeneDx (1818331) Filer | Form EFFECT | |
| 09/05/2025 6:03 AM | GeneDx (1818331) Filer | Form POS AM | |
| 09/03/2025 5:31 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/27/2025 8:01 PM | GeneDx (1818331) Issuer Ryan Jason (1585017) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/27/2025 4:20 PM | GeneDx (1818331) Subject Ryan Jason (1585017) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/26/2025 10:27 AM | CMLS Holdings LLC (1822257) Filed by GeneDx (1818331) Subject | Form SCHEDULE 13D/A | |
| 08/22/2025 6:14 PM | Casdin Partners Master Fund, L.P. (1534265) Reporting GeneDx (1818331) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/22/2025 5:55 PM | Casdin Capital, LLC (1534261) Reporting Casdin Eli (1534264) Reporting Casdin Partners GP, LLC (1534260) Reporting Casdin Partners Master Fund, L.P. (1534265) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2025 11:33 AM | GeneDx (1818331) Subject SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (1638555) Filed by | Form SCHEDULE 13G/A | |
| 08/07/2025 6:41 PM | Casdin Eli (1534264) Reporting GeneDx (1818331) Issuer | Form 4/A | |
| 07/30/2025 11:19 AM | GeneDx (1818331) Subject WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1644956) Filed by | Form SCHEDULE 13G | |
| 07/29/2025 7:18 AM | GeneDx (1818331) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/29/2025 6:21 AM | GeneDx (1818331) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/11/2025 3:03 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/11/2025 3:04 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 1:31 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 1:32 PM | GeneDx (1818331) Issuer Stueland Katherine (1689575) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2025 6:53 PM | GeneDx (1818331) Subject Stueland Katherine (1689575) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2025 6:53 PM | Feeley Kevin (1944119) Reporting GeneDx (1818331) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |